Decline in Incident Coronary Heart Disease

Abstract

HomeCirculationVol. 117, No. 5Decline in Incident Coronary Heart Disease Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBDecline in Incident Coronary Heart DiseaseWhy Are the Rates Falling? Russell V. Luepker, MD, MS Russell V. LuepkerRussell V. Luepker From the University of Minnesota, School of Public Health, Division of Epidemiology and Community Health, Minneapolis. Search for more papers by this author Originally published5 Feb 2008https://doi.org/10.1161/CIRCULATIONAHA.107.747477Circulation. 2008;117:592–593In the fall of 1979, the National Heart, Lung, and Blood Institute held a conference on the decline in coronary heart disease (CHD) death rates. It was apparent that in the previous 10 to 15 years, the epidemic crested and began to fall.1 The reasons for this decline were unclear, but many hypotheses were offered. Explanations ranged from death classification artifact, new coronary care units, and coronary surgery to broad social change. Many were more than willing to take credit for this change, but few data were available. A search for explanations began.Article p 598Three major themes emerged as possible explanations: (1) primary prevention through risk factor reduction, including public health measures such as reduction in cigarettes and clinical approaches such as lipid and blood pressure management; (2) modern care for acute coronary syndromes, including emergency services, coronary care units, and revascularization strategies; and (3) secondary prevention in those with known CHD, including revascularization, medications, and lifestyle approaches. Each of these has substantial clinical trial evidence to support its utility in reducing new cases (incidence), recurrent events, and/or death.Early attempts to understand the causes were hampered by a lack of data. Stern2 suggested that a decline in mortality was related to improved diet, reduced smoking, reduced blood pressure, and increased leisure-time physical activity. He noted in 1979 that coronary care units might play a role, but he doubted that surgical revascularization was common enough to affect national rates. Later in 1984, Goldman et al3 performed a modeling experiment based on available risk factor data from the National Health and Nutrition Examination Survey (NHANES) using clinical trial data to estimate magnitude of effect. With these data, they suggested that about half of the decline was due to risk factor reduction and half to other factors.More recently, reports from the United States and Western Europe have used surveys and registries to estimate the relative contributions of the different components influencing disease reduction. In 2001, Goldman et al4 modeled costs of various approaches to the decline, including widespread risk factor change, concluding that this was the most cost-efficient approach. Capewell and colleagues,5 using the population of Scotland as a basis, suggested that 51% of the decline in CHD mortality was due to risk factor reduction, with the main component being reduced cigarette smoking. Forty percent was attributed to treatment, including care for acute myocardial infarction, heart failure, revascularization, and secondary prevention. A similar study in Finland explaining the decline in CHD mortality between 1982 and 1997 suggested that improved CHD treatments explain ≈23% of the mortality reduction and risk factor reduction explained 53% to 72%.6A recent study in the United States examined CHD events from 1980 to 2000. It attributed 47% of the decline to CHD treatment and 44% to changes in cholesterol, blood pressure, smoking, and physical activity. The authors noted that the benefits of risk factor reduction were offset by increasing weight in the population.7The study by Hardoon and colleagues8 in this issue of Circulation analyzes changes in CHD incidence with unique data and statistical approach. Using the totality of family practices in the United Kingdom, they randomly sampled these practices. In the context of the universal care of the National Health Service in the United Kingdom, this technique provides a population-based sample. At baseline and 20 years later, they measured risk factors using standard methods, ensuring comparability with stored samples. This technique results in risk factor data that are directly relevant to this population. Finally, using methods from the Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) study,9 they were able to evaluate incidence. Incidence or first event is the best indicator of the role of primary prevention in CHD rates.Hardoon and colleagues found a 62% decline in age-adjusted CHD incidence from the baseline survey (1978 to 1982) to 2004. This translates into a 3.8% decrease per annum. Of the various factors measured, cigarette smoking, systolic blood pressure, and non–high-density lipoprotein cholesterol all fell. High-density lipoprotein cholesterol, body mass index, and physical activity rose, with body mass index as a negative factor. In total, this accounted for 46% of the decline in incident myocardial infarction.The study is well done, and the conclusions are justified. It has weaknesses, however, including a loss to follow-up that resulted in a participation rate of 77% in the final survey. In addition, the study includes only men and contains no data on women. Finally, much of the interim data do not include measured risk factors but only questionnaires.These findings in the United Kingdom are particularly interesting. For trends in CHD mortality, the UK mortality peaked in the 1970s and then began to fall. This lagged the United States by ≈10 years.10 Similarly, despite the central role played by UK investigators in major clinical trials of risk factor reduction, many experts in the United Kingdom were ambivalent about risk factors and the diet hypothesis.11 They also comment that revascularization procedures were less likely in the United Kingdom than in other places. During the period of this study, the United Kingdom was among the lowest of Western European countries for revascularization procedures, presumably influencing use of the treatment for both angina pectoris and acute coronary disease.12,13 These rates continue to be lower than those in the United States.The United Kingdom, like many other industrialized countries, has observed a substantive fall in CHD death rates over the past decades. This study of incidence highlights the role of widespread prevention in contributing to this decline. The data from this study are confirmatory in both direction and magnitude with other studies done in Europe and the United States. All find that risk factors play a crucial role in the trends, approximating 50%. This finding does not negate the effect of acute care and secondary prevention, both of which play important roles. Nonetheless, falls in population-wide levels of cigarette smoking and systolic blood pressure, as well as favorable lipid effects, are attributed to both public health and clinic care strategies. These data confirm and extend our understanding of the CHD epidemic and inform our attempts to eliminate it.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresNone.FootnotesCorrespondence to Russell V. Luepker, Mayo Professor, Division of Epidemiology and Community Health, University of Minnesota, School of Public Health, 1300 S Second St, Ste 300, Minneapolis, MN 55454-1015. E-mail [email protected] References 1 Feinleib M, Havlik RJ, Thom T. Conference on the decline in coronary heart disease mortality. In: Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality, National Heart, Lung, and Blood Institute, National Institute of Health; October 24–25, 1978, Bethesda, Maryland. Bethesda, Md: US Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health; 1979. NIH publication no. 79–1610.Google Scholar2 Stern MP. The recent decline in ischemic heart disease mortality. Ann Intern Med. 1979; 91: 630–640.CrossrefMedlineGoogle Scholar3 Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. Ann Intern Med. 1984; 101: 825–836.CrossrefMedlineGoogle Scholar4 Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol. 2001; 38: 1012–1017.CrossrefMedlineGoogle Scholar5 Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999; 81: 380–386.CrossrefMedlineGoogle Scholar6 Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162: 764–773.CrossrefMedlineGoogle Scholar7 Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007; 356: 2388–2398.CrossrefMedlineGoogle Scholar8 Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation. 2008; 117: 598–604.LinkGoogle Scholar9 Tunstall-Pedoe H, ed. MONICA Monograph and Multimedia Sourcebook. Geneva, Switzerland: World Health Organization; 2003.Google Scholar10 Unal B, Alison A, Capewell. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004; 109: 1101–1107.LinkGoogle Scholar11 Oliver M. Dietary cholesterol, plasma cholesterol and coronary heart disease. Br Heart J. 1976; 38: 214–218.CrossrefMedlineGoogle Scholar12 Windecker S, Maier-Rudolph W, Bonzel T, Heyndrickx G, Lablanche JM, Morice MC, Muhlberger V, Neukaus KL, Piscione F, van den Brand M, Wijns W, Meier B, for the Working Group Coronary Circulation of the European Society of Cardiology. Intervention cardiology in Europe 1995. Eur Heart J. 1999; 20: 484–495.CrossrefMedlineGoogle Scholar13 Togni M, Balmer F, Pfiffner D, Maier W, Zeiher AM, Meier B, for the Working Group Interventional Cardiology and Coronary Pathophysiology of the European Society of Cardiology. Percutaneous coronary interventions in Europe 1992–2001. Eur Heart J. 2004; 25: 1208–1213.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Mattioli A, Sciomer S, Cocchi C, Maffei S and Gallina S (2020) Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2020.05.020, 30:9, (1409-1417), Online publication date: 1-Aug-2020. Kieser T (2017) Invited Commentary, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2017.10.021, 104:6, (1907-1908), Online publication date: 1-Dec-2017. Dunn A, Rittmueller L and Whitmire B (2016) Health Care Spending Slowdown From 2000 To 2010 Was Driven By Lower Growth In Cost Per Case, According To A New Data Source, Health Affairs, 10.1377/hlthaff.2015.1109, 35:1, (132-140), Online publication date: 1-Jan-2016. Patel A and Webster R (2016) The potential and value of epidemiology in curbing non-communicable diseases, Global Health, Epidemiology and Genomics, 10.1017/gheg.2016.10, 1, . Anthony D, Dyson P, Lv J, Thankappan K, Fernández M and Matthews D (2015) Reducing Health Risk Factors in Workplaces of Low and Middle-Income Countries, Public Health Nursing, 10.1111/phn.12189, 32:5, (478-487), Online publication date: 1-Sep-2015. Sulo G, Igland J, Nygård O, Vollset S, Ebbing M and Tell G (2013) Favourable trends in incidence of AMI in Norway during 2001–2009 do not include younger adults: a CVDNOR project, European Journal of Preventive Cardiology, 10.1177/2047487313495993, 21:11, (1358-1364), Online publication date: 1-Nov-2014. Papandreou C and Tuomilehto H (2013) Coronary heart disease mortality in relation to dietary, lifestyle and biochemical risk factors in the countries of the Seven Countries Study: a secondary dataset analysis, Journal of Human Nutrition and Dietetics, 10.1111/jhn.12187, 27:2, (168-175), Online publication date: 1-Apr-2014. Lim K, Kang C, Choi J and Kim J (2013) Korean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig, The Korean Journal of Physiology & Pharmacology, 10.4196/kjpp.2013.17.4.283, 17:4, (283), . Lim K, Lim D and Kim J (2013) Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach, Journal of Ginseng Research, 10.5142/jgr.2013.37.283, 37:3, (283-292), Online publication date: 15-Jul-2013. Sivasankaran S (2013) Heart-Healthy Diet Cardiovascular Diseases, 10.1201/b14663-20, (277-308), Online publication date: 16-Apr-2013. Colombo C, Macedo R, Fernandes-Silva M, Caporal A, Stinghen A, Costantini C, Baena C, Guarita-Souza L and Faria-Neto J (2013) Efeitos de curto prazo de um programa de atividade física moderada em pacientes com síndrome metabólica, Einstein (São Paulo), 10.1590/S1679-45082013000300011, 11:3, (324-330), Online publication date: 1-Sep-2013. Gupta R, Guptha S, Gupta V, Agrawal A, Gaur K and Deedwania P (2011) Twenty-year trends in cardiovascular risk factors in India and influence of educational status, European Journal of Preventive Cardiology, 10.1177/1741826711424567, 19:6, (1258-1271), Online publication date: 1-Dec-2012. Gupta R and Deedwania P (2011) Interventions for Cardiovascular Disease Prevention, Cardiology Clinics, 10.1016/j.ccl.2010.10.005, 29:1, (15-34), Online publication date: 1-Feb-2011. Kim H, Lim K, Kang C, Kim B, Roh Y, Kwon J, Kim S, Ejaz S and Kim J (2011) Influence of ginsenoside-Re against myocardial infarction in isolated heart, Molecular & Cellular Toxicology, 10.1007/s13273-011-0003-3, 7:1, (15-24), Online publication date: 1-Mar-2011. Gupta R, Guptha S, Joshi R and Xavier D (2011) Translating evidence into policy for cardiovascular disease control in India, Health Research Policy and Systems, 10.1186/1478-4505-9-8, 9:1, Online publication date: 1-Dec-2011. Bolognese L (2010) Changing patterns of ST elevation myocardial infarction epidemiology, American Heart Journal, 10.1016/j.ahj.2010.10.008, 160:6, (S1-S3), Online publication date: 1-Dec-2010. Schopfer D, Patel V, Chiang J and Kao J (2015) Hospitals with Percutaneous Coronary Intervention Capability Have Greater Adherence to Established Myocardial Infarction Guidelines, Hospital Practice, 10.3810/hp.2010.04.289, 38:2, (9-13), Online publication date: 1-Apr-2010. Adabag A, Luepker R, Roger V and Gersh B (2010) Sudden cardiac death: epidemiology and risk factors, Nature Reviews Cardiology, 10.1038/nrcardio.2010.3, 7:4, (216-225), Online publication date: 1-Apr-2010. Kuch B, von Scheidt W, Ehmann A, Kling B, Greschik C, Hoermann A and Meisinger C (2009) Extent of the Decrease of 28-Day Case Fatality of Hospitalized Patients With Acute Myocardial Infarction Over 22 Years, Circulation: Cardiovascular Quality and Outcomes, 2:4, (313-319), Online publication date: 1-Jul-2009. Kim J (2009) Protective Roles of Ginseng Saponin in Cardiac Ischemia and Reperfusion Injury, Journal of Ginseng Research, 10.5142/JGR.2009.33.4.283, 33:4, (283-293), Online publication date: 31-Dec-2010. Gersh B (2009) How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors? Evidence From a Prospective Population-Based Study, Yearbook of Cardiology, 10.1016/S0145-4145(09)79526-7, 2009, (330-331), Online publication date: 1-Jan-2009. Talukder M, Zweier J and Periasamy M (2009) Targeting calcium transport in ischaemic heart disease, Cardiovascular Research, 10.1093/cvr/cvp264, 84:3, (345-352), Online publication date: 1-Dec-2009. Dyson P, Anthony D, Fenton B, Stevens D, Champagne B, Li L, Lv J, Ramírez Hernández J, Thankappan K, Matthews D and Zhu S (2015) Successful Up-Scaled Population Interventions to Reduce Risk Factors for Non-Communicable Disease in Adults: Results from the International Community Interventions for Health (CIH) Project in China, India and Mexico, PLOS ONE, 10.1371/journal.pone.0120941, 10:4, (e0120941) Kouvonen A, Koskinen A, Varje P, Kokkinen L, De Vogli R, Väänänen A and Hernandez-Boussard T (2014) National Trends in Main Causes of Hospitalization: A Multi-Cohort Register Study of the Finnish Working-Age Population, 1976–2010, PLoS ONE, 10.1371/journal.pone.0112314, 9:11, (e112314) Olson J, Bild D, Kronmal R and Burke G (2016) Legacy of MESA, Global Heart, 10.1016/j.gheart.2016.08.004, 11:3, (269) February 5, 2008Vol 117, Issue 5 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.107.747477PMID: 18250277 Originally publishedFebruary 5, 2008 KeywordspopulationEditorialscoronary diseasepreventionepidemiologyrisk factorsPDF download Advertisement SubjectsAcute Coronary Syndromes